Genetic Technologies Limi...

NASDAQ: GENE · Real-Time Price · USD
0.77
0.01 (0.65%)
At close: Nov 14, 2024, 10:00 PM

Genetic Balance Sheet Statement

Financials in AUD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Cash & Equivalents
1.02M 7.85M 11.73M 20.9M
Short-Term Investments
18.79K 17.44K 13.26K 1.86K
Long-Term Investments
n/a 4.11M n/a n/a
Other Long-Term Assets
81.7K -4.24M -6.08M -9.54M
Receivables
209.25K 191.9K 2.42M 1.07M
Inventory
206.47K 325.89K 398.15K 76.93K
Other Current Assets
1.92M 1.73M 18.23K 1.86K
Total Current Assets
3.7M 10.5M 14.72M 22.24M
Property-Plant & Equipment
264.49K 599.18K 953.33K 637.71K
Goodwill & Intangibles
2.14M 3.64M 5.13M 9.64M
Total Long-Term Assets
2.49M 4.24M 6.08M 735.57K
Total Assets
6.19M 14.86M 20.8M 22.97M
Account Payables
1.46M 837.95K 1.15M 269.67K
Deferred Revenue
479.44K 849.21K 814.15K 635.00
Short-Term Debt
643.55K n/a n/a n/a
Other Current Liabilities
547.24K 779.38K 968.52K 490.69K
Total Current Liabilities
4.2M 3.31M 3.81M 1.41M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
137.72K 30.44K 22.5K 8.86K
Total Long-Term Liabilities
160.64K 381.62K 558.91K 33.27K
Total Liabilities
4.36M 3.69M 4.37M 1.44M
Total Debt
875.19K 532.85K 652.53K 204.04K
Common Stock
163.82M 161.34M 155.14M 153.57M
Retained Earnings
-166.38M -156.72M -150.21M -143.08M
Comprehensive Income
4.39M 6.54M 11.5M 11.03M
Shareholders Equity
1.83M 11.16M 16.43M 21.53M
Total Investments
18.79K 17.44K 13.26K 1.86K